One person, one family, one community at a time, the Hunter Medical Research Institute (HMRI) fights the illnesses affecting lives throughout the world. Our translational research model aligns over 1500 researchers, students and support staff from Hunter New England Health and the University of Newcastle, inspiring new discoveries to deliver a healthier future.

Throughout Newcastle and the Hunter region researchers, students and support staff are working across six HMRI Research Programs to prevent, cure and treat a diverse range of serious illnesses by translating research findings made in the laboratory into real health treatments and preventative strategies. Internationally-recognised research outcomes are being achieved in asthma and airway diseases, cancer, diabetes, mental health, nutrition, pregnancy and reproduction, stroke and more. Collaborations are being conducted with institutes on all points of the globe.

HMRI provides vital funding and facilities to fuel research, but the heart and soul of the Institute are people – the researchers, the generous donors and supporters, the committed volunteers, and the patients who participate in trials and ultimately benefit from the research results.

Upcoming Events

2021 Hunter Children's Research Foundation Virtual Awards Night
2021 Hunter Children's Research Foundation Virtual Awards Night
October 28, 2021 - 6:00pm to 6:30pm

Please join us for the 2021 Hunter Children's Research Foundation Awards Night.

Latest News & Articles

Oct 20 2021

Learn more about HMRI's 2020 Researchers of the Year, Distinguished Laureate Professor NIck Talley, Professor Tracy Burrows and Associate Professor Andrew Gardner.

Oct 14 2021

Newcastle-based visual artist Brittany Ferns unveiled a piece inspired by the 2020 HMRI Award for Research Excellence recipient Distinguished Laureate Professor Nick Talley AC

Oct 8 2021

Research comparing the brain health of retired athletes from collision and non-collision sports will be part of a comprehensive and collaborative concussion project being led by the Australian Institute of Sport (AIS).

Oct 7 2021

Encouraging preliminary results from an ongoing phase 1 study have triggered the announcement of phase 2 studies for a first-in-class nasal spray to protect people from respiratory viral diseases such as COVID-19 and influenza.